000 | 01868 a2200517 4500 | ||
---|---|---|---|
005 | 20250512095258.0 | ||
264 | 0 | _c19710422 | |
008 | 197104s 0 0 eng d | ||
022 | _a0021-972X | ||
024 | 7 |
_a10.1210/jcem-32-4-522 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSherins, R J | |
245 | 0 | 0 |
_aPituitary and testicular function studies. I. Experience with a new gonadal inhibitor, 17-alpha-pregn-4-en-20-yno-(2,3-d)isoxazol-17-ol (Danazol). _h[electronic resource] |
260 |
_bThe Journal of clinical endocrinology and metabolism _cApr 1971 |
||
300 |
_a522-31 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article | ||
650 | 0 | 4 |
_a17-Ketosteroids _xblood |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAndrogens _xbiosynthesis |
650 | 0 | 4 |
_aAndrostanes _xblood |
650 | 0 | 4 |
_aAntimetabolites _xpharmacology |
650 | 0 | 4 |
_aChorionic Gonadotropin _xpharmacology |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aClomiphene |
650 | 0 | 4 |
_aDehydroepiandrosterone _xblood |
650 | 0 | 4 | _aDepression, Chemical |
650 | 0 | 4 | _aFeedback |
650 | 0 | 4 |
_aFollicle Stimulating Hormone _xurine |
650 | 0 | 4 |
_aGonadotropins, Pituitary _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypothalamo-Hypophyseal System _xphysiology |
650 | 0 | 4 |
_aLeydig Cells _xdrug effects |
650 | 0 | 4 |
_aLuteinizing Hormone _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOxazoles _xpharmacology |
650 | 0 | 4 | _aPituitary Function Tests |
650 | 0 | 4 |
_aPituitary Gland _xdrug effects |
650 | 0 | 4 |
_aPregnanes _xpharmacology |
650 | 0 | 4 |
_aTestosterone _xblood |
700 | 1 | _aGandy, H M | |
700 | 1 | _aThorslund, T W | |
700 | 1 | _aPaulsen, C A | |
773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 32 _gno. 4 _gp. 522-31 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1210/jcem-32-4-522 _zAvailable from publisher's website |
999 |
_c4256355 _d4256355 |